Phase 1 Investor
Phase 1 Investor is our most exclusive – and expensive – investment advisory at Stansberry Research.
That's because Phase 1 Investor takes a "venture capital" approach to investing, seeking out small-cap speculative stocks with outstanding growth potential. The service focuses on natural resource stocks, as well as emerging technologies in the high-tech, life sciences, and biotechnology industries.
Over his 18-year-plus career, Phase 1 editor Frank Curzio's approach to investing – which blends value, growth, top-down, and technical analysis – has regularly produced triple-digit winners for his subscribers. He's been a guest on various Fox Business News and CNBC financial news programs, including Jim Cramer's Mad Money.
In other words, Frank is an incredibly connected analyst... a critical attribute to the success of Phase 1. You can only find the world's best opportunities in this space when you have an extensive contact list of corporate insiders, scientific researchers, bankers, and consultants. After spending 18-plus years studying and networking with some of the smartest people on Wall Street, Frank has developed just such a list.
We pay a premium for Frank's experience and contacts. That's why Phase 1 Investor, published on the first Tuesday of each month, is our most expensive research service. It's also why it's so successful.
As subscriber Jack Milligan said of this service, "I've subscribed to many research advisories in the past 30 years, and Phase 1 is by far the best in my judgment."
You might also like...
Meet Frank Curzio
Frank Curzio, Jr. is the editor of Small Stock Specialist, an investment advisory which focuses on undervalued growth stocks with small market caps.
Prior to joining Stansberry & Associates in 2009, Frank worked for one of the richest hedge-fund managers on Wall Street, where his job was to analyze stocks in the "under $10" sector.
Issues are published the first Tuesday of every month